Full View

A single molecular descriptor to predict solution behavior of therapeutic antibodies

JS Kingsbury, A Saini, SM Auclair, L Fu, MM Lantz… - Science …, 2020 - science.org
Despite the therapeutic success of monoclonal antibodies (mAbs), early identification of
developable mAb drug candidates with optimal manufacturability, stability, and delivery …
被引用次数：122 相关文章

A single molecular descriptor to predict solution behavior of therapeutic antibodies

JS Kingsbury, A Saini, SM Auclair, L Fu… - Science …, 2020 - pubmed.ncbi.nlm.nih.gov
Despite the therapeutic success of monoclonal antibodies (mAbs), early identification of
developable mAb drug candidates with optimal manufacturability, stability, and delivery …

[引用][C] A single molecular descriptor to predict solution behavior of therapeutic antibodies

JS Kingsbury, A Saini, SM Auclair, L Fu… - Science …, 2020 - ui.adsabs.harvard.edu
A single molecular descriptor to predict solution behavior of therapeutic antibodies - NASA/ADS
Now on home page ads icon ads Enable full ADS view NASA/ADS A single molecular …

A single molecular descriptor to predict solution behavior of therapeutic antibodies.

JS Kingsbury, A Saini, SM Auclair, L Fu… - Science …, 2020 - europepmc.org
Despite the therapeutic success of monoclonal antibodies (mAbs), early identification of
developable mAb drug candidates with optimal manufacturability, stability, and delivery …

[引用][C] A single molecular descriptor to predict solution behavior of therapeutic antibodies

JS Kingsbury, A Saini, SM Auclair, L Fu, MM Lantz… - Science …, 2020 - cir.nii.ac.jp
A single molecular descriptor to predict solution behavior of therapeutic antibodies | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML] nih.gov

[HTML][HTML] A single molecular descriptor to predict solution behavior of therapeutic antibodies

JS Kingsbury, A Saini, SM Auclair, L Fu… - Science …, 2020 - ncbi.nlm.nih.gov
Despite the therapeutic success of monoclonal antibodies (mAbs), early identification of
developable mAb drug candidates with optimal manufacturability, stability, and delivery …